These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16418309)

  • 1. Do oncologists discuss expensive anti-cancer drugs with their patients?
    Thomson J; Schofield P; Mileshkin L; Agalianos E; Savulescu J; Zalcberg J; Jefford M
    Ann Oncol; 2006 Apr; 17(4):702-8. PubMed ID: 16418309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Communication about high-cost drugs in oncology--the patient view.
    Kaser E; Shaw J; Marven M; Swinburne L; Boyle F
    Ann Oncol; 2010 Sep; 21(9):1910-1914. PubMed ID: 20332139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey.
    Schrag D; Hanger M
    J Clin Oncol; 2007 Jan; 25(2):233-7. PubMed ID: 17210946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs.
    Berry SR; Bell CM; Ubel PA; Evans WK; Nadler E; Strevel EL; Neumann PJ
    J Clin Oncol; 2010 Sep; 28(27):4149-53. PubMed ID: 20697077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do oncologists believe new cancer drugs offer good value?
    Nadler E; Eckert B; Neumann PJ
    Oncologist; 2006 Feb; 11(2):90-5. PubMed ID: 16476830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To tell or not to tell: the community wants to know about expensive anticancer drugs as a potential treatment option.
    Mileshkin L; Schofield PE; Jefford M; Agalianos E; Levine M; Herschtal A; Savulescu J; Thomson JA; Zalcberg JR
    J Clin Oncol; 2009 Dec; 27(34):5830-7. PubMed ID: 19786663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paternalism in practice: informing patients about expensive unsubsidised drugs.
    Dare T; Findlay M; Browett P; Amies K; Anderson S
    J Med Ethics; 2010 May; 36(5):260-4. PubMed ID: 20439327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitude of Iranian Medical Oncologists Toward Economic Aspects, and Policy-making in Relation to New Cancer Drugs.
    Daroudi R; Mirzania M; Zendehdel K
    Int J Health Policy Manag; 2015 Oct; 5(2):99-105. PubMed ID: 26927395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discussing and prescribing expensive unfunded anticancer drugs in Australia.
    Karikios DJ; Mileshkin L; Martin A; Ferraro D; Stockler MR
    ESMO Open; 2017; 2(2):e000170. PubMed ID: 28761744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer therapy costs influence treatment: a national survey of oncologists.
    Neumann PJ; Palmer JA; Nadler E; Fang C; Ubel P
    Health Aff (Millwood); 2010; 29(1):196-202. PubMed ID: 20048377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discussion of costs and financial burden in clinical practice: A survey of medical oncologists in Australia.
    Agarwal A; Karikios DJ; Stockler MR; Morton RL
    PLoS One; 2022; 17(10):e0273620. PubMed ID: 36269711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients and Physicians Can Discuss Costs of Cancer Treatment in the Clinic.
    Kelly RJ; Forde PM; Elnahal SM; Forastiere AA; Rosner GL; Smith TJ
    J Oncol Pract; 2015 Jul; 11(4):308-12. PubMed ID: 26015459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weighing up the benefits and harms of a new anti-cancer drug: a survey of Australian oncologists.
    Chim L; Salkeld G; Stockler MR; Mileshkin L
    Intern Med J; 2015 Aug; 45(8):834-42. PubMed ID: 25950615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes of medical oncologists toward palliative care for patients with advanced and incurable cancer: report on a survery by the European Society of Medical Oncology Taskforce on Palliative and Supportive Care.
    Cherny NI; Catane R;
    Cancer; 2003 Dec; 98(11):2502-10. PubMed ID: 14635087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American oncologists' views of internet use by cancer patients: a mail survey of American Society of Clinical Oncology members.
    Helft PR; Hlubocky F; Daugherty CK
    J Clin Oncol; 2003 Mar; 21(5):942-7. PubMed ID: 12610198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of gynecologic oncologists regarding the end-of-life discussion: a pilot study.
    El-Sahwi KS; Illuzzi J; Varughese J; Carusillo N; Ratner ES; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Santin AD
    Gynecol Oncol; 2012 Mar; 124(3):471-3. PubMed ID: 22014628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faculty of Radiation Oncology 2014 workforce census.
    Leung J; Munro PL; James M;
    J Med Imaging Radiat Oncol; 2015 Dec; 59(6):717-27. PubMed ID: 26511456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Views of American oncologists about the purposes of clinical trials.
    Joffe S; Weeks JC
    J Natl Cancer Inst; 2002 Dec; 94(24):1847-53. PubMed ID: 12488478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary survey of oncologists' perceptions of quality of life information.
    Bezjak A; Ng P; Taylor K; MacDonald K; Depetrillo AD
    Psychooncology; 1997 Jun; 6(2):107-13. PubMed ID: 9205968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey of Michigan dentists and radiation oncologists on oral care of patients undergoing head and neck radiation therapy.
    Patel Y; Bahlhorn H; Zafar S; Zwetchkenbaum S; Eisbruch A; Murdoch-Kinch CA
    J Mich Dent Assoc; 2012 Jul; 94(7):34-45. PubMed ID: 22970504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.